LCM
PRDS

Lynx1 Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Lynx1 Capital Management’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$7.06M Buy
2023
Q1 		$4.39M Buy
2022
Q4 		$5.08M Buy
2022
Q3 		$4.21M Buy
2022
Q2 		$6.69M Buy
2022
Q1 		$11.9M Buy
2021
Q4 		$6.57M Buy